EE04297B1 - Budesoniidi ja formoterooli uus kasutamine - Google Patents

Budesoniidi ja formoterooli uus kasutamine

Info

Publication number
EE04297B1
EE04297B1 EEP200000145A EEP200000145A EE04297B1 EE 04297 B1 EE04297 B1 EE 04297B1 EE P200000145 A EEP200000145 A EE P200000145A EE P200000145 A EEP200000145 A EE P200000145A EE 04297 B1 EE04297 B1 EE 04297B1
Authority
EE
Estonia
Prior art keywords
formoterol
budesonide
new use
new
Prior art date
Application number
EEP200000145A
Other languages
English (en)
Estonian (et)
Inventor
Bauer Carl-Axel
Trofast Jan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20408325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04297(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000145A publication Critical patent/EE200000145A/xx
Publication of EE04297B1 publication Critical patent/EE04297B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200000145A 1997-09-19 1998-09-09 Budesoniidi ja formoterooli uus kasutamine EE04297B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use
PCT/SE1998/001599 WO1999015182A1 (en) 1997-09-19 1998-09-09 New use for budesonide and formoterol

Publications (2)

Publication Number Publication Date
EE200000145A EE200000145A (et) 2001-02-15
EE04297B1 true EE04297B1 (et) 2004-06-15

Family

ID=20408325

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000145A EE04297B1 (et) 1997-09-19 1998-09-09 Budesoniidi ja formoterooli uus kasutamine

Country Status (38)

Country Link
US (2) US7897646B2 (enExample)
EP (2) EP1210943B1 (enExample)
JP (1) JP2001517630A (enExample)
KR (1) KR20010024140A (enExample)
CN (1) CN1149998C (enExample)
AR (1) AR013506A1 (enExample)
AT (2) ATE329599T1 (enExample)
AU (1) AU757235B2 (enExample)
BR (1) BR9812325A (enExample)
CA (1) CA2302700C (enExample)
CY (1) CY1106156T1 (enExample)
CZ (1) CZ295250B6 (enExample)
DE (2) DE69807239T2 (enExample)
DK (2) DK1210943T3 (enExample)
EE (1) EE04297B1 (enExample)
ES (2) ES2182357T3 (enExample)
HK (1) HK1045812B (enExample)
HU (1) HUP0003848A2 (enExample)
ID (1) ID24838A (enExample)
IL (1) IL134773A (enExample)
IN (1) IN190791B (enExample)
IS (1) IS2715B (enExample)
MX (1) MXPA00002615A (enExample)
MY (1) MY127812A (enExample)
NO (1) NO327176B1 (enExample)
NZ (1) NZ503173A (enExample)
PL (1) PL190782B1 (enExample)
PT (2) PT1014993E (enExample)
RU (1) RU2199322C2 (enExample)
SA (1) SA98190773B1 (enExample)
SE (1) SE9703407D0 (enExample)
SI (2) SI1014993T1 (enExample)
SK (1) SK285330B6 (enExample)
TR (1) TR200000726T2 (enExample)
TW (1) TW546140B (enExample)
UA (1) UA72446C2 (enExample)
WO (1) WO1999015182A1 (enExample)
ZA (1) ZA988516B (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
CA2347856C (en) * 1998-11-13 2009-02-17 Jagotec Ag Dry powder for inhalation
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9928311D0 (en) 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
PL365736A1 (en) * 2001-02-06 2005-01-10 Innovata Biomed Limited Bimodal dry powder formulation for inhalation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
CA2500065A1 (en) * 2002-09-30 2004-04-15 Acusphere, Inc. Sustained release porous microparticles for inhalation
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
ES2384641T3 (es) 2005-07-14 2012-07-10 Lithera, Inc. Formulación lipolítica que potencia la liberación mantenida para el tratamiento localizado del tejido adiposo
CA2631492A1 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
PL2077830T3 (pl) * 2006-10-17 2013-04-30 Lithera Inc Sposoby, kompozycje i formulacje do leczenia orbitopatii tarczycowej
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
SI3106149T1 (sl) 2009-05-29 2020-07-31 Pearl Therapeutics, Inc. Sestavki za pljučno dostavo muskarinskih antagonistov z dolgotrajnim delovanjem in agonistov beta-2 adrenergičnega receptorja z dolgotrajnim delovanjem in povezani postopki in sistemi
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2010144628A2 (en) * 2009-06-09 2010-12-16 Elevation Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
CN102000090A (zh) * 2009-08-31 2011-04-06 北京利乐生制药科技有限公司 一种以布地奈德与阿福特罗为活性成分的复方制剂
BR112012017556A2 (pt) * 2010-01-15 2016-08-16 Lithera Inc formulações de torta liofilizada
GEP201606551B (en) 2010-11-24 2016-10-10 Novamedica Llc Selective, lipophilic, and long-acting beta agonists monotherapeutic formulations tions and methods for cosmetic treatment of adiposity and contour bulging
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
CN102362860A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
HK1219059A1 (zh) 2013-03-15 2017-03-24 珍珠治疗公司 用於微粒晶体材料的状态调节的方法和系统
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
WO2017093758A1 (en) 2015-12-04 2017-06-08 Mexichem Fluor S.A. De C.V. Pharmaceutical composition
JP7470646B2 (ja) 2018-06-14 2024-04-18 アストラゼネカ・ユーケイ・リミテッド コルチコステロイド医薬組成物を用いて喘息の症状を治療および予防するための方法
WO2021048171A1 (en) * 2019-09-10 2021-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to improve phagocytosis
US12329759B2 (en) 2019-10-17 2025-06-17 Trustees Of Boston University Methods and compositions relating to lung function

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0416950B1 (en) 1989-09-08 1993-08-11 Glaxo Group Limited Medicaments
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
US5250286A (en) * 1990-05-07 1993-10-05 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl) 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5444521A (en) 1991-07-15 1995-08-22 Canon Kabushiki Kaisha Image fixing device capable of controlling heating overshoot
EP1086697A2 (en) 1991-12-18 2001-03-28 AstraZeneca AB New combination of formoterol and budesonide
SK282826B6 (sk) 1991-12-18 2002-12-03 Aktiebolaget Astra Farmaceutická kompozícia na podávanie inhaláciou s obsahom formoterolu a budesonidu a jej použitie
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9519692D0 (en) 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
ATE289994T1 (de) * 1995-11-24 2005-03-15 Glaxosmithkline Spa Chinolin-derivate
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
ID24063A (id) 1997-06-27 2000-07-06 Astra Ab Kombinasi obat anti asma
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination

Also Published As

Publication number Publication date
ID24838A (id) 2000-08-24
CA2302700C (en) 2010-11-23
CZ2000950A3 (cs) 2000-06-14
EP1014993A1 (en) 2000-07-05
US8461211B2 (en) 2013-06-11
EP1210943A1 (en) 2002-06-05
ATE222106T1 (de) 2002-08-15
ZA988516B (en) 1999-03-19
MXPA00002615A (es) 2002-04-24
NZ503173A (en) 2001-08-31
CN1149998C (zh) 2004-05-19
ATE329599T1 (de) 2006-07-15
CZ295250B6 (cs) 2005-06-15
NO20001401L (no) 2000-03-17
HK1045812B (en) 2006-12-22
PL190782B1 (pl) 2006-01-31
DK1014993T3 (da) 2002-11-11
DE69834955D1 (de) 2006-07-27
NO327176B1 (no) 2009-05-04
EE200000145A (et) 2001-02-15
DK1210943T3 (da) 2006-09-18
EP1210943B1 (en) 2006-06-14
BR9812325A (pt) 2000-09-05
SE9703407D0 (sv) 1997-09-19
ES2182357T3 (es) 2003-03-01
PT1210943E (pt) 2006-09-29
KR20010024140A (ko) 2001-03-26
DE69834955T2 (de) 2007-01-25
IL134773A0 (en) 2001-04-30
CA2302700A1 (en) 1999-04-01
US20060189587A9 (en) 2006-08-24
IL134773A (en) 2005-03-20
MY127812A (en) 2006-12-29
IS2715B (is) 2011-02-15
SK285330B6 (sk) 2006-11-03
RU2199322C2 (ru) 2003-02-27
IN190791B (enExample) 2003-08-23
SI1014993T1 (en) 2003-02-28
US20110097282A1 (en) 2011-04-28
NO20001401D0 (no) 2000-03-17
PL339295A1 (en) 2000-12-04
SI1210943T1 (sl) 2006-10-31
CN1271287A (zh) 2000-10-25
HUP0003848A2 (hu) 2001-08-28
AR013506A1 (es) 2000-12-27
SA98190773B1 (ar) 2006-10-02
ES2266322T3 (es) 2007-03-01
DE69807239D1 (de) 2002-09-19
IS5407A (is) 2000-03-15
TW546140B (en) 2003-08-11
JP2001517630A (ja) 2001-10-09
HK1045812A1 (en) 2002-12-13
DE69807239T2 (de) 2003-04-10
PT1014993E (pt) 2002-12-31
US7897646B2 (en) 2011-03-01
AU9192898A (en) 1999-04-12
SK3892000A3 (en) 2000-12-11
EP1014993B1 (en) 2002-08-14
US20020042404A1 (en) 2002-04-11
CY1106156T1 (el) 2011-06-08
UA72446C2 (uk) 2005-03-15
WO1999015182A1 (en) 1999-04-01
TR200000726T2 (tr) 2000-09-21
AU757235B2 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
EE04297B1 (et) Budesoniidi ja formoterooli uus kasutamine
DE60010662D1 (de) Kombinationen von formoterol und fluticasonpropionat für asthma
ID27937A (id) Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
ID27922A (id) KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
ID22957A (id) Senyawa dan penggunaannya
NO984094L (no) Utladningsreaktor og anvendelse av samme
ID26402A (id) Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya
ATE275940T1 (de) Medizinische aerosolformulierungen von formoterol
IS5510A (is) Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða
ID24196A (id) Komposisi dan penggunaan
ID26728A (id) Amida-amida baru dengan pensubstitusi heterosiklik, pembuatan dan penggunaannya
FI965204A0 (fi) Bromelaiinin lääkekäyttö
ID28368A (id) Tanda-tanda mikrosatelite tumbuhan dan metode terhadap penggunaannya
ID26979A (id) Zat pelapis dan penggunaanya
NO996438D0 (no) Ny kombinasjon av astmamedikamenter
EE200200163A (et) Loteprednooli ja ß2-adrenoretseptori agonistide uued kombinatsioonid
ID23693A (id) Formulasi bambuterol, pembuatan dan penggunaanya
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
EE200100020A (et) NAB1 ja NAB2 farmatseutiline kasutamine
ID23048A (id) Komposisi farmasi protein hedgehog dan penggunaanny a
ID30541A (id) Peptida-peptida kecil dan penggunannya pada penyembuhan asma dan radang

Legal Events

Date Code Title Description
HD1A Correction of address
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231